Disseminated cutaneous Mycobacterium haemophilum infection in a patient on infliximab for rheumatoid arthritis. Issue 1 (17th January 2022)

• Record Type: Journal Article
• Authors: Harder, Samuel; Oberholtzer, Sarah; Shumilak, Geoffrey; Wudel, Beverly
• Is Part Of: BMJ case reports. Volume 15:Issue 1(2022)
• Publication Date: 2022-01-17
• Subjects: infections -- rheumatoid arthritis -- unwanted effects / adverse reactions -- biological agents; Medicine -- Case studies -- Periodicals; 610.5
• DOI: 10.1136/bcr-2021-245853
• Languages: English
• ISSNs: 1757-790X

Abstract

Abstract : Mycobacterium haemophilum is a rarely encountered pathogen that is difficult to identify given its unique growth requirements. It is most often seen in adult patients who are immunosuppressed due to advanced HIV or haematological malignancy. Our case highlights a typical presentation of an atypical pathogen in a patient with rheumatoid arthritis receiving anti-tumour necrosis factor therapy. This case represents an important patient population in whom this previously rare infection is increasingly common.